Revenue decreased 97.8%
Revenue changed -97.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -97.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed -98.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +68.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -297764 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed -498 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net income changed +73.9% from the comparable as-filed period.
Cash & equivalents changed +91.3% from the comparable as-filed period.
Research & development changed +6.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.